Key Intermediate for Deucravacitinib Synthesis: 4,6-Dichloro-N-(Methyl-d3)-3-Pyridazinecarboxamide
Essential building block for advanced autoimmune therapies, ensuring high purity and precise molecular structure.
Get a Quote & SampleProduct Core Value
4,6-Dichloro-N-(Methyl-d3)-3-Pyridazinecarboxamide
This chemical compound is a vital Pharmaceutical Intermediate used in the synthesis of Deucravacitinib, a groundbreaking oral selective TYK2 inhibitor. Its precise molecular structure and high purity (>98%) are critical for the successful development of therapies targeting autoimmune diseases like plaque psoriasis. As a deuterated compound, it plays a crucial role in forming the specific pyridazine scaffold required for Deucravacitinib's therapeutic efficacy.
- Discover the critical role of this Deucravacitinib intermediate in advanced pharmaceutical synthesis.
- Learn about the importance of high purity (>98%) for effective pharmaceutical intermediates in drug development.
- Explore the benefits of using a deuterated compound like 4,6-dichloro-N-(trideuteriomethyl)pyridazine-3-carboxamide for targeted therapies.
- Understand how CAS 1609393-89-6 facilitates the production of cutting-edge treatments for autoimmune conditions.
Key Advantages
High Purity and Quality
With a purity exceeding 98%, this intermediate ensures reliable and effective outcomes in complex pharmaceutical synthesis, a key factor when you buy 4,6-dichloro-N-(trideuteriomethyl)pyridazine-3-carboxamide.
Deuteration for Enhanced Efficacy
The deuterated methyl group is integral to the Deucravacitinib molecule, contributing to its pharmacological profile and therapeutic performance in treating autoimmune diseases.
Critical Building Block
This compound serves as an essential Pyridazinecarboxamide derivative, forming a core part of the Deucravacitinib structure, vital for its targeted action.
Key Applications
Deucravacitinib Synthesis
A primary application is its use in the chemical synthesis of Deucravacitinib, a significant advancement in autoimmune disorder treatment.
Pharmaceutical Research
Serves as a key component in ongoing pharmaceutical research and development for new and improved autoimmune therapies.
Autoimmune Disease Therapy
The intermediate is fundamental to creating medications that manage conditions such as plaque psoriasis, psoriatic arthritis, and lupus.
Chemical Intermediate Supply
Reliable sourcing of CAS 1609393-89-6 is crucial for pharmaceutical manufacturers requiring consistent access to this vital compound.